In DMD myoblasts from humans, miR-31 silencing enhances dystrophin and therefore miR-31 regulation is suggested as a probable curative approach to ameliorate the DMD phenotype [104]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.